Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2024. Review the filing volume, DOL certification record, and offered-wage context below.
San Diego, CA NAICS: 541714
U.S. Department of Labor's OFLC discloses 17 Labor Condition Application filings naming Mirati Therapeutics, Inc. from FY2023 through FY2024, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 41 H-1B petitions naming Mirati Therapeutics, Inc. through FY2024, and approved nearly every one of them: 100% approved (41 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Mirati Therapeutics, Inc. is listed in 17 DOL LCA filings, more filings than 90% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $161,905. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2024). Based in San Diego, CA.
Mirati Therapeutics, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
17 12842nd of 122824 higher than 109,982 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2024
Derived from this employer's disclosed LCAs on file (FY2023–FY2024), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $109,000–$288,444 .
DOL LCA release change
On 17 LCAs with comparable offered vs prevailing wages, Mirati Therapeutics, Inc. averages about 25.5% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (64.7% of LCA filings).
Only 17 LCAs on file for Mirati Therapeutics, Inc., and 94.1% land in SAN DIEGO, CA. Treat rates as descriptive of a small sample. DOL cert on file: 100%.
Certification Rate
100%
Very high DOL cert
Avg. Salary
$161,905
Well above portal avg
Total Workers
17
Small worker count
Compensation range for H-1B positions at Mirati Therapeutics, Inc.
Wage vs. DOL Minimum
+25.5%
Above DOL floor
national avg +17.8%
Typical DOL Wage Level
Fully Competent (Level IV)
64.7% of LCA filings
Full-Time Positions
100%
Primary Worksite County
SAN DIEGO, CA
94.1% of LCA filings
Most frequently listed job titles at Mirati Therapeutics, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Manager, Pharmacovigilance Submissions | 3 | $134,000 |
| Senior Manager, Clinical Data Management | 2 | $175,659 |
| Associate Director, Biostatistics | 2 | $190,000 |
| Sr. Manager, Statistical Programming | 1 | $164,274 |
| Sr. Manager, Pharmacovigilance | 1 | $150,000 |
| Senior Scientist, Chemical Process R&D | 1 | $125,000 |
| Senior Scientist, Analytical R&D and QC | 1 | $146,016 |
| Senior Scientist, Analytical Development | 1 | $146,932 |
| Senior Manager, Analytical R&D and QC | 1 | $185,640 |
| Principal Scientist, Product Development | 1 | $164,000 |
| Principal Clinical Data Manager | 1 | $139,755 |
| Executive Medical Director | 1 | $288,444 |
| Biochemist, Senior Scientist | 1 | $109,000 |
Cross-state DOL neighbors for Mirati Therapeutics, Inc. - LCA filing-count and offered-wage axes, outside CA.
Nearest cross-state employer filers by LCA filing count (17 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($161,905 here).
Mirati Therapeutics, Inc. is listed in 17 DOL Labor Condition Application filings covering 17 listed worker positions from FY2023 to FY2024. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Mirati Therapeutics, Inc. ranks #12321 by total LCA filing count (17 filings). 109,982 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Mirati Therapeutics, Inc. has a 100% DOL certification rate, with 17 out of 17 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Mirati Therapeutics, Inc.'s LCAs is $161,905. Listed wages range from $109,000 to $288,444 and are not verified actual compensation.
The top job titles in Mirati Therapeutics, Inc.'s LCA filing records include Manager, Pharmacovigilance Submissions, Senior Manager, Clinical Data Management, Associate Director, Biostatistics. The most common listed title is Manager, Pharmacovigilance Submissions with 3 LCA filings at an average listed offered wage of $134,000. This does not establish actual job openings, hiring, or approved petitions.
Mirati Therapeutics, Inc. is headquartered in San Diego, CA. Their H-1B workers are distributed across 2 states, with the most positions in CA, KS.
No, Mirati Therapeutics, Inc. is not classified as H-1B dependent.
Mirati Therapeutics, Inc. is listed in 8 LCA filings in FY2023 and 9 in FY2024. The average listed offered wage changed from $166,840 to $157,518. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 17 LCAs (Δ 0 heavier vs Mirati Therapeutics, Inc.); CERT-SOLID · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 17 LCAs (Δ 0 heavier vs Mirati Therapeutics, Inc.); CERT-SOLID · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 17 LCAs (Δ 0 heavier vs Mirati Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 17 LCAs (Δ 0 heavier vs Mirati Therapeutics, Inc.); CERT-SOFT · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
CA pole at 33,631 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Mirati Therapeutics, Inc.'s MICRO-BOOK.
Open the CA state board after the ABS peers. Mirati Therapeutics, Inc. stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Mirati Therapeutics, Inc.'s WAGE-ELITE offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Mirati Therapeutics, Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.